These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9106733)

  • 1. Acute haloperidol attenuates the hypomotility induced with 7-hydroxy-DPAT.
    Lynch MR; Ormsby JL
    Neuroreport; 1997 Feb; 8(3):611-5. PubMed ID: 9106733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the effects of 7-OH-DPAT, a dopamine D3-receptor agonist, on morphine-induced hyperlocomotion by diabetes.
    Kamei J; Saitoh A
    Life Sci; 1996; 59(9):773-80. PubMed ID: 8761030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective effects on prefrontal cortex serotonin by dopamine D3 receptor agonism: interaction with low-dose haloperidol.
    Lynch MR
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Oct; 21(7):1141-53. PubMed ID: 9421827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C; Cummins R; Gnoffo Z; Kew JN
    Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain.
    Vahid-Ansari F; Robertson GS
    Eur J Neurosci; 1996 Dec; 8(12):2605-11. PubMed ID: 8996810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs.
    Mefford IN; Roth KA; Agren H; Barchas JD
    Brain Res; 1988 Dec; 475(2):380-4. PubMed ID: 2905626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
    Caine SB; Geyer MA; Swerdlow NR
    Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.
    Shimizu S; Tatara A; Sato M; Sugiuchi T; Miyoshi S; Andatsu S; Kizu T; Ohno Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():157-62. PubMed ID: 24368396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
    Barik S; de Beaurepaire R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The locomotor effects of a putative dopamine D3 receptor agonist in developing rats.
    Frantz K; Babcock D; Van Hartesveldt C
    Eur J Pharmacol; 1996 Apr; 302(1-3):1-6. PubMed ID: 8790984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol blocks increased locomotor activity elicited by carbachol infusion into the ventral hippocampal formation.
    Brenner DM; Bardgett ME
    Pharmacol Biochem Behav; 1998 Jul; 60(3):759-64. PubMed ID: 9678662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol.
    Carey R; Damianopoulos E; De Palma G
    Pharmacol Biochem Behav; 2000 Aug; 66(4):863-72. PubMed ID: 10973527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
    Rogóz Z; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of haloperidol and (-)-sulpiride on dopamine agonist-induced hypoactivity.
    Storey VJ; Middlemiss DN; Reavill C
    Neuropharmacology; 1995 Apr; 34(4):449-55. PubMed ID: 7566477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
    Van den Buuse M
    Eur J Pharmacol; 1993 Oct; 243(2):169-77. PubMed ID: 8276066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.